Mehryar Amirkiai
Podiatry · Sunnyvale
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 1
- 1 carrier
- Office
- 1
Offices
1 location
Hospitals listed: El Camino Health. That is not proof they admit you there this week.
Plans that list them
1 plan · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Mehryar Amirkiai’s office at (408) 245-3230 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$101,749
Medicare paid this office $101,749 for 295 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 120 | $19,392 | $81 |
| Removal of fingernails or toenails, 6 or more nails | 111 | $16,466 | $40 |
| New patient visit (30+ min) | 114 | $11,342 | $99 |
| Removal of noncancer thickened skin growth, 2-4 growths | 45 | $10,375 | $78 |
| Removal of noncancer thickened skin growth, 1 growth | 29 | $3,724 | $69 |
See all 12 services
| Short return visit (20+ min) | 120 | $19,392 | $81 |
| Removal of fingernails or toenails, 6 or more nails | 111 | $16,466 | $40 |
| New patient visit (30+ min) | 114 | $11,342 | $99 |
| Removal of noncancer thickened skin growth, 2-4 growths | 45 | $10,375 | $78 |
| Removal of noncancer thickened skin growth, 1 growth | 29 | $3,724 | $69 |
| Removal of fingernails or toenails, 1-5 nails | 30 | $2,125 | $32 |
| Simple separation of fingernail or toenail from nail bed, first nail | 18 | $1,899 | $105 |
| Short return visit | 21 | $1,236 | $51 |
| X-ray of foot, 2 views | 31 | $1,145 | $28 |
| Injection into tendon or ligament | 20 | $1,092 | $50 |
| X-ray of foot, minimum of 3 views | 15 | $659 | $35 |
| Placement of strapping to ankle or foot | 14 | $323 | $23 |
Procedures Medicare counted
| Lower limb (leg) arthroscopy (minimally invasive joint repair) | 1-10 | None |
| Removal of nail tissue | 543 | More than 85% of doctors who do this |
| Removal of tissue | 78 | More than 83% of doctors who do this |
| Removal or shaving of skin growth | 286 | More than 92% of doctors who do this |
| Skin biopsy | 1-10 | None |
| Spinal fusion | 1-10 | None |
Who their Medicare patients are
295 Original Medicare patients in 2024. Average age 79 · Women 56% · Also on Medicaid 10% · Health risk score 1.23. At or below the middle of the specialty; the typical podiatry clinician is at 1.55.
Conditions among them: High blood pressure 75% · Diabetes 30% · Coronary heart disease 29% · Chronic kidney disease 24% · Atrial fibrillation 22% · Depression 15% · Heart failure 14% · Cancer 14% · COPD 12% · Stroke 11% · Dementia 8%.
The office billed $234,309, Medicare allowed $130,676 and paid $101,749; for 1,395 services of 57 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 295 | 1,395 | 79 | 1.23 | $234,309 | $101,749 |
| 2023 | 278 | 1,510 | 79 | 1.32 | $290,287 | $147,363 |
| 2022 | 268 | 1,408 | 80 | 1.31 | $223,067 | $106,908 |
| 2021 | 249 | 1,293 | 80 | 1.31 | $179,374 | $86,543 |
| 2020 | 262 | 2,312 | 81 | 1.44 | $261,428 | $116,580 |
| 2019 | 311 | 1,999 | 80 | 1.38 | $234,256 | $105,751 |
| 2018 | 257 | 1,129 | 80 | 1.53 | $141,784 | $63,730 |
| 2017 | 239 | 976 | 80 | 1.55 | $134,893 | $55,461 |
| 2016 | 222 | 1,331 | 80 | 1.56 | $185,595 | $77,223 |
| 2015 | 277 | 1,156 | 82 | 1.47 | $136,952 | $61,655 |
| 2014 | 295 | 1,279 | 82 | 1.35 | $143,425 | $60,890 |
| 2013 | 481 | 1,924 | 83 | 1.76 | $212,747 | $92,772 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 12 services
| Removal of fingernails or toenails, 6 or more nails | 118 | $15,609 | $40 |
| Short return visit (20+ min) | 104 | $14,828 | $81 |
| New patient visit (30+ min) | 99 | $9,623 | $97 |
| Removal of noncancer thickened skin growth, 2-4 growths | 41 | $8,085 | $79 |
| Removal of noncancer thickened skin growth, 1 growth | 31 | $4,254 | $71 |
| Removal of fingernails or toenails, 1-5 nails | 36 | $2,100 | $30 |
| Simple separation of fingernail or toenail from nail bed, first nail | 16 | $1,791 | $112 |
| Short return visit | 24 | $1,424 | $53 |
| X-ray of foot, 2 views | 27 | $1,025 | $28 |
| X-ray of foot, minimum of 3 views | 23 | $847 | $34 |
| Injection into tendon or ligament | 13 | $691 | $49 |
| Placement of strapping to ankle or foot | 11 | $271 | $25 |
2022: 9 services
| Removal of fingernails or toenails, 6 or more nails | 122 | $16,964 | $41 |
| Short return visit (20+ min) | 92 | $13,256 | $82 |
| New patient visit (30+ min) | 97 | $9,544 | $98 |
| Removal of noncancer thickened skin growth, 2-4 growths | 30 | $8,370 | $83 |
| Removal of noncancer thickened skin growth, 1 growth | 33 | $5,737 | $72 |
| Simple separation of fingernail or toenail from nail bed, first nail | 17 | $2,035 | $113 |
| Removal of fingernails or toenails, 1-5 nails | 22 | $1,866 | $31 |
| Short return visit | 18 | $1,159 | $53 |
| X-ray of foot, 2 views | 19 | $597 | $28 |
2021: 9 services
| Removal of fingernails or toenails, 6 or more nails | 126 | $18,583 | $41 |
| Short return visit (20+ min) | 75 | $11,451 | $84 |
| New patient visit (30+ min) | 77 | $7,330 | $95 |
| Removal of noncancer thickened skin growth, 2-4 growths | 33 | $7,063 | $79 |
| Removal of noncancer thickened skin growth, 1 growth | 35 | $5,733 | $68 |
| Short return visit | 23 | $1,354 | $52 |
| Removal of fingernails or toenails, 1-5 nails | 19 | $1,342 | $31 |
| X-ray of foot, 2 views | 24 | $900 | $28 |
| X-ray of foot, minimum of 3 views | 15 | $470 | $29 |
2020: 8 services
| Removal of fingernails or toenails, 6 or more nails | 139 | $17,347 | $43 |
| Short return visit (20+ min) | 79 | $9,558 | $72 |
| Removal of noncancer thickened skin growth, 2-4 growths | 36 | $6,785 | $71 |
| New patient visit (30+ min) | 67 | $6,771 | $101 |
| Removal of noncancer thickened skin growth, 1 growth | 32 | $4,439 | $64 |
| Simple separation of fingernail or toenail from nail bed, first nail | 20 | $2,409 | $110 |
| Removal of fingernails or toenails, 1-5 nails | 24 | $1,160 | $31 |
| Short return visit | 19 | $949 | $45 |
2019: 12 services
| Removal of fingernails or toenails, 6 or more nails | 170 | $22,403 | $42 |
| Short return visit (20+ min) | 97 | $12,171 | $67 |
| Removal of noncancer thickened skin growth, 2-4 growths | 52 | $9,299 | $64 |
| New patient visit (30+ min) | 102 | $9,252 | $91 |
| Removal of skin and tissue, 20.0 sq cm or less | 14 | $5,592 | $110 |
| Removal of noncancer thickened skin growth, 1 growth | 45 | $4,673 | $53 |
| Simple separation of fingernail or toenail from nail bed, first nail | 15 | $1,659 | $104 |
| Removal of fingernails or toenails, 1-5 nails | 31 | $1,614 | $31 |
| Short return visit | 29 | $1,556 | $42 |
| Injection into tendon or ligament | 21 | $976 | $44 |
| X-ray of foot, 2 views | 19 | $614 | $25 |
| X-ray of foot, minimum of 3 views | 13 | $397 | $28 |
2018: 10 services
| Removal of fingernails or toenails, 6 or more nails | 133 | $17,000 | $41 |
| Short return visit (20+ min) | 94 | $11,139 | $64 |
| Removal of noncancer thickened skin growth, 2-4 growths | 37 | $7,714 | $55 |
| New patient visit (30+ min) | 68 | $6,120 | $90 |
| Removal of skin and tissue, 20.0 sq cm or less | 15 | $3,458 | $108 |
| Removal of noncancer thickened skin growth, 1 growth | 29 | $2,913 | $46 |
| Removal of fingernails or toenails, 1-5 nails | 21 | $1,209 | $29 |
| Short return visit | 18 | $958 | $40 |
| Injection into tendon or ligament | 12 | $583 | $45 |
| X-ray of foot, 2 views | 12 | $349 | $25 |
2017: 10 services
| Removal of fingernails or toenails, 6 or more nails | 131 | $13,902 | $37 |
| Short return visit (20+ min) | 77 | $7,080 | $61 |
| New patient visit (30+ min) | 70 | $6,092 | $87 |
| Removal of skin and tissue, 20.0 sq cm or less | 14 | $5,972 | $103 |
| Removal of noncancer thickened skin growth, 2-4 growths | 30 | $4,884 | $52 |
| Removal of noncancer thickened skin growth, 1 growth | 29 | $2,379 | $42 |
| Removal of noncancer thickened skin growth, more than 4 growths | 13 | $1,746 | $58 |
| Removal of fingernails or toenails, 1-5 nails | 18 | $827 | $29 |
| Short return visit | 18 | $824 | $36 |
| X-ray of foot, 2 views | 15 | $364 | $23 |
2016: 13 services
| Removal of fingernails or toenails, 6 or more nails | 137 | $16,670 | $36 |
| Short return visit (20+ min) | 113 | $11,428 | $63 |
| Removal of skin and tissue, 20.0 sq cm or less | 13 | $9,164 | $102 |
| Removal of noncancer thickened skin growth, 2-4 growths | 50 | $4,630 | $50 |
| New patient visit (30+ min) | 53 | $3,873 | $73 |
| Removal of noncancer thickened skin growth, 1 growth | 43 | $2,268 | $36 |
| Removal of tissue from wound, 20.0 sq cm or less | 11 | $1,531 | $70 |
| Removal of noncancer thickened skin growth, more than 4 growths | 13 | $1,479 | $53 |
| Short return visit | 32 | $1,239 | $38 |
| Injection into tendon or ligament | 19 | $1,136 | $49 |
| X-ray of foot, 2 views | 25 | $772 | $22 |
| Removal of fingernails or toenails, 1-5 nails | 18 | $667 | $26 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 13 | $55 | None |
2015: 10 services
| Removal of fingernails or toenails, 6 or more nails | 174 | $18,954 | $39 |
| Short return visit (20+ min) | 60 | $6,791 | $64 |
| New patient visit (30+ min) | 61 | $5,732 | $94 |
| Removal of noncancer thickened skin growth, 2-4 growths | 55 | $5,632 | $53 |
| Removal of noncancer thickened skin growth, 1 growth | 47 | $4,026 | $44 |
| Removal of noncancer thickened skin growth, more than 4 growths | 11 | $1,590 | $59 |
| Removal of fingernails or toenails, 1-5 nails | 36 | $1,408 | $28 |
| Short return visit | 25 | $1,203 | $41 |
| Injection into tendon or ligament | 13 | $841 | $56 |
| X-ray of foot, 2 views | 19 | $657 | $25 |
2014: 12 services
| Removal of fingernails or toenails, 6 or more nails | 187 | $21,884 | $38 |
| Short return visit (20+ min) | 68 | $6,756 | $63 |
| New patient visit (30+ min) | 54 | $4,767 | $88 |
| Removal of noncancer thickened skin growth, 1 growth | 62 | $4,676 | $41 |
| Removal of noncancer thickened skin growth, 2-4 growths | 50 | $4,658 | $52 |
| Removal of noncancer thickened skin growth, more than 4 growths | 16 | $1,966 | $61 |
| Short return visit | 33 | $1,328 | $37 |
| Injection into tendon or ligament | 18 | $1,190 | $50 |
| Removal of fingernails or toenails, 1-5 nails | 30 | $1,003 | $27 |
| X-ray of foot, 2 views | 19 | $623 | $26 |
| X-ray of foot, minimum of 3 views | 12 | $555 | $31 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 16 | $48 | None |
2013: 15 services
| Removal of fingernails or toenails, 6 or more nails | 306 | $30,967 | $37 |
| Short return visit (20+ min) | 80 | $10,006 | $63 |
| New patient visit (30+ min) | 81 | $7,305 | $90 |
| Removal of noncancer thickened skin growth, 2-4 growths | 59 | $6,839 | $51 |
| Removal of noncancer thickened skin growth, 1 growth | 68 | $5,386 | $44 |
| Removal of tissue from wound, 20.0 sq cm or less | 12 | $2,884 | $74 |
| Removal of fingernails or toenails, 1-5 nails | 69 | $2,690 | $27 |
| Removal of noncancer thickened skin growth, more than 4 growths | 14 | $1,406 | $54 |
| X-ray of foot, 2 views | 25 | $913 | $29 |
| Short return visit | 14 | $756 | $42 |
| X-ray of foot, minimum of 3 views | 19 | $727 | $32 |
| Injection into tendon or ligament | 11 | $624 | $48 |
| Removal of fingernails or toenails, 6 or more nails | 21 | $538 | $19 |
| Trimming of fingernails or toenails | 25 | $396 | $9 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 12 | $67 | None |
Drugs they prescribed that Part D paid
$2,148
Pharmacies billed $2,148 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
105 generic and 16 brand-name prescriptions · $2,148 in drug cost · 28 antibiotic prescriptions to 17 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ketoconazole | 24 | $430 | $18 |
| Cephalexin | 17 | $224 | $13 |
| Levothyroxine | 11 | $110 | $10 |
Year by year
| 2024 | 121 | 60 | None | 13% | $2,148 |
| 2023 | 120 | 50 | 12% (14) | None | $2,023 |
| 2022 | 79 | 37 | None | None | $4,832 |
| 2021 | 66 | 37 | None | None | $2,133 |
| 2020 | 63 | 32 | None | None | $1,942 |
| 2019 | 76 | 37 | None | None | $3,290 |
| 2018 | 52 | 34 | None | None | $2,607 |
| 2017 | 62 | 34 | None | None | $5,077 |
| 2016 | 75 | 40 | None | 17% | $8,570 |
| 2015 | 106 | 40 | None | 11% | $15,891 |
| 2014 | 81 | 40 | 0% (0) | 20% | $5,464 |
| 2013 | 65 | 34 | None | None | $4,876 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 3 drugs
| Ketoconazole | 18 | $434 | $24 |
| Hydrocodone-Acetaminophen | 14 | $103 | $7 |
| Famotidine | 13 | $15 | $1 |
2022: 1 drug
| Ketoconazole | 17 | $625 | $37 |
2021: 1 drug
| Ketoconazole | 22 | $1,101 | $50 |
2020: 1 drug
| Ketoconazole | 30 | $1,161 | $39 |
2019: 1 drug
| Ketoconazole | 28 | $1,553 | $55 |
2017: 2 drugs
| Econazole Nitrate | 22 | $3,331 | $151 |
| Cephalexin | 12 | $87 | $7 |
2016: 2 drugs
| Econazole Nitrate | 28 | $4,785 | $171 |
| Clotrimazole | 13 | $549 | $42 |
2015: 2 drugs
| Econazole Nitrate | 47 | $10,638 | $226 |
| Ibuprofen | 11 | $79 | $7 |
2014: 2 drugs
| Econazole Nitrate | 29 | $1,254 | $43 |
| Clotrimazole | 11 | $222 | $20 |
Money from drug and device companies
$1,137 in 2025
| 2025 | 11 | 31 | None | $1,137 |
| 2024 | 9 | 38 | None | $2,947 |
| 2023 | 9 | 18 | None | $752 |
| 2022 | 9 | 27 | None | $958 |
| 2021 | 10 | 32 | None | $2,952 |
| 2020 | 5 | 8 | None | $379 |
| 2019 | 7 | 13 | None | $475 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Amgen | Krystexxa | $297 | 8 payments
|
| Smith+Nephew | Grafix | $281 | 6 payments
|
| Stryker | Tensix | $200 | 6 payments
|
| Paragon 28 | Hammertube Sterile Implant Kits | $112 | 1 payment
|
| MIMEDX Group | None | $82 | 4 payments
|
| Bioventus | Exogen Ultrasound Bone Healing System | $42 | 1 payment
|
See all 31 published payments
| Bioventus | Meals · 2025-12-11 | Exogen Ultrasound Bone Healing System | $42 |
| Stryker | Meals · 2025-11-11 | Allopure | $45 |
| Stryker | Meals · 2025-10-01 | Tensix | $56 |
| Orthofix Medical | Meals · 2025-09-10 | Physio-Stim | $31 |
| Amgen | Meals · 2025-08-27 | Krystexxa | $28 |
| Stryker | Meals · 2025-08-26 | Prostep Mica | $25 |
| Paratek Pharmaceuticals | Meals · 2025-08-06 | Nuzyra | $20 |
| Stryker | Meals · 2025-08-01 | Flexband | $29 |
| Amgen | Meals · 2025-07-30 | Krystexxa | $11 |
| MIMEDX Group | Meals · 2025-07-21 | None | $25 |
| Organogenesis | Meals · 2025-07-09 | Affinity | $33 |
| Smith+Nephew | Meals · 2025-07-03 | Collagenase Santyl | $8 |
| Paragon 28 | Meals · 2025-06-26 | Hammertube Sterile Implant Kits | $112 |
| MIMEDX Group | Meals · 2025-06-16 | None | $17 |
| Amgen | Meals · 2025-06-11 | Krystexxa | $32 |
| Stryker | Meals · 2025-05-21 | Dart-Fire | $22 |
| Amgen | Meals · 2025-05-16 | Krystexxa | $11 |
| Smith+Nephew | Meals · 2025-05-14 | Grafix | $148 |
| Smith+Nephew | Meals · 2025-05-08 | Grafix | $42 |
| Amgen | Meals · 2025-04-14 | Krystexxa | $29 |
| Amgen | Meals · 2025-04-08 | Krystexxa | $125 |
| Smith+Nephew | Meals · 2025-04-01 | Collagenase Santyl | $21 |
| Vertex Pharmaceuticals | Meals · 2025-03-26 | Journavx | $21 |
| Smith+Nephew | Meals · 2025-03-19 | Collagenase Santyl | $31 |
| Amgen | Meals · 2025-03-05 | Krystexxa | $31 |
| Smith+Nephew | Meals · 2025-02-26 | Stravix | $31 |
| Abbvie | Meals · 2025-02-13 | Botox | $19 |
| MIMEDX Group | Meals · 2025-01-29 | None | $25 |
| Stryker | Meals · 2025-01-22 | Actishield | $22 |
| MIMEDX Group | Meals · 2025-01-22 | None | $15 |
| Amgen | Meals · 2025-01-08 | Krystexxa | $31 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $2,947
| Arthrex | None | $1,471 | 16 payments
|
| Evolution Surgical | None | $785 | 5 payments
|
| Stryker | Prostep | $257 | 1 payment
|
| Organogenesis | Affinity | $137 | 5 payments
|
| Smith+Nephew | Collagenase Santyl | $103 | 4 payments
|
| Amgen | Krystexxa | $84 | 3 payments
|
| Abbvie | Botox | $55 | 2 payments
|
| Pacira Pharmaceuticals | Exparel | $36 | 1 payment
|
| Reprise Biomedical | Miro3d | $19 | 1 payment
|
2023: $752
| Treace Medical Concepts | Lapiplasty System | $230 | 2 payments
|
| Nevro | Senza | $198 | 3 payments
|
| Smith+Nephew | Collagenase Santyl | $116 | 4 payments
|
| Organogenesis | Puraply | $81 | 4 payments
|
| Orthofix Medical | Physio-Stim | $37 | 1 payment
|
| Horizon Therapeutics plc | Krystexxa | $26 | 1 payment
|
| Biotissue Holdings | Neox | $25 | 1 payment
|
| Paragon 28 | Mtp | $23 | 1 payment
|
| Bioventus | Exogen Ultrasound Bone Healing System | $16 | 1 payment
|
2022: $958
| Smith+Nephew | Collagenase Santyl | $383 | 14 payments
|
| Organogenesis | Puraply | $194 | 3 payments
|
| Musculoskeletal Transplant Foundation | None | $156 | 4 payments
|
| Paratek Pharmaceuticals | Nuzyra | $117 | 1 payment
|
| GRT US Holding | Qutenza | $27 | 1 payment
|
| Ethicon US | Surgicel Nu-Knit | $24 | 1 payment
|
| Bioventus | Exogen Ultrasound Bone Healing System | $20 | 1 payment
|
| Ortho Dermatologics a division of Bausch Health US | Jublia | $19 | 1 payment
|
| ConvaTec | Aquacel Ag+ | $17 | 1 payment
|
2021: $2,952
| Evolution Surgical | None | $1,244 | 2 payments
|
| Treace Medical Concepts | Lapiplasty System | $890 | 7 payments
|
| Smith+Nephew | Collagenase Santyl | $214 | 8 payments
|
| Organogenesis | Puraply | $188 | 3 payments
|
| Ethicon US | Stratafix | $123 | 1 payment
|
| Musculoskeletal Transplant Foundation | None | $122 | 4 payments
|
| Alfasigma USA | None | $75 | 3 payments
|
| AbbVie | Dalvance | $56 | 2 payments
|
| Paratek Pharmaceuticals | Nuzyra | $24 | 1 payment
|
| Medtronic | Venaseal | $16 | 1 payment
|
2020: $379
| Smith+Nephew | Stravix | $127 | 4 payments
|
| Zimmer Biomet Holdings | Stratum Foot Plating System | $107 | 1 payment
|
| Wright Medical Technology | Ortholoc | $100 | 1 payment
|
| Organogenesis | Puraply | $31 | 1 payment
|
| Paragon 28 | None | $13 | 1 payment
|
2019: $475
| Smith+Nephew | Pico Single Use Negative Pressure Wound Therapy | $188 | 6 payments
|
| Osiris Therapeutics | Stravix | $119 | 1 payment
|
| Galderma Laboratories L.P. | None | $100 | 2 payments
|
| Wright Medical Technology | Ortholoc | $18 | 1 payment
|
| Ortho Dermatologics a division of Bausch Health US | Bryhali | $18 | 1 payment
|
| Arthrosurface | Hemicap Mtp Resurfacing | $17 | 1 payment
|
| Organogenesis | Apligraf | $15 | 1 payment
|
Professional record
- NPI
- 1487617072
- Licence
- CA E3895
- Trained
- California School of Podiatric Medicine, 1992
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 213ES0103X (213ES0103X)
- Mailing address
- 697 E Remington Dr, Ste A, Sunnyvale, CA, 94087
- NPI first listed
- 2006-04-06
- NPI last updated
- 2008-02-22
This is when the NPI record was last certified, not a medical board exam.